References
- Schachter J. DFA, ETA, PCR, LCR and other technologies: what tests should be used for diagnosis of chlamydia infections? Immunol Invest. 1997;26:157-161.
- Thylefors B, Dawson CR, Jones BR, et al. A simple system for the assessment of trachoma and its complications. Bull WHO. 1987; 65:477–483.
- Taylor HR, Rapoza PA, West S, et al. The epidemiology of infection in trachoma. Invest Ophthalmol Vis Sci. 1989;30:1823–1833.
- Baral K, Osaki S, Shreshta B, et al. Reliability of clinical diagnosis in identifying infectious trachoma in a low-prevalence area of Nepal. Bull WHO. 1999;77:461–466.
- Stata User's Guide, Release 7. College Station, Texas: Stata Press, 2001.
- Them J, Zhao P, Liu H, et al. Does clinical activity indicate ocular chlamydial infection in areas with low prevalences of trachoma? Ophthalmic Epidemiol. 2002; 9:263–269.
- Bailey RL, Hayes L, Pickett M, et al. Molecular epidemiology of trachoma in a Gambian village. Br J Ophthalmol. 1994;78:813–817.
- Bobo LD, Novak N, Murioz B, et al. Severe disease in children with trachoma is associated with persistent Chlamydia trachomatis infection. J Infect Dis. 1997;176: 1524-153o.
- Bird M, Dawson CR, Schachter JS, et al. Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas? J Infect Dis. 2003; 187:1669–1673.
- Assaad FA, Maxwell-Lyons E Systematic observer variation in trachoma studies. Bull WHO. 1967; 36:885–900.
- Tielsch JM, West KP Jr, Johnson GJ, et al. Trachoma grading: observer trials conducted in southern Malawi. Br J Ophthalmol. 1987;71:371–374.
- Briljant LB, Lepkowski JM, Musch DC. Reliability of ophthalmic diagnoses in an epidemiologic survey. Am J Epidemiol. 1983;118: 265–279.
- Ostergaard L, Birkelund S, Christiansen G. Use of polymerase chain reaction for detection of Chlamydia trachomatis. J Clin Microbiol. 1990;28:1254–1260.
- Taylor HR, Siler JA, Mkocha HA, et al. Longitudinal study of the microbiology of endemic trachoma. J Clin Microbiol. 1991;29:1593–1595.
- Peterson EM, Darrow V, Blanding J, et al. Reproducibility problems with the AMPLICOR PCR Chlamydia trachomatis test. J Clin Microbiol. 1997:35:957–959.
- Smieja M, Mahony JB, Goldsmith CH, et al. Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumonia in clinical specimens. J Clth Microbiol. 2001;39:1796–1801.
- Roche Molecular Systems I. AMPLICOR CT/NG test for Chlamydia trachomatis. Branchburg, NJ: Roche Diagnostics, 1999;19.
- Fleiss JL. Statistical Methods for Rates and Proportions, 2nd ed. New York: John Wiley and Sons, 1981.
- Landis J, Koch G. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174.
- Bailey RL, Arullendran P, Whittle HC, Mabey DC. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet. 1993;342:453–456.
- Dawson CR, Jawetz E, Hanna L, et al. Experimental inclusion conjunctivitis in man: partial resistance to reinfection. Am J Epidemiol. I 966;84:4 I 1–425.
- Mitsui Y, Konishi K, Nishimura A, et al. Experiments in human volunteers with trachoma and inclusion conjunctivitis agent. Br J Ophthalmol. 1962;46:651–659.
- Smolin G, Thoft RA. The Cornea Scientific Foundations and Clinical Practice, 2nd ed. Boston/Toronto: Little, Brown and Company, 1987.
- Wood RT, Dawson CR. Bacteriologic studies of a trachomatous population. Am J Ophthalmol. 1967;63(suppl): 1298–1301.
- Diamont J, Moncada J, Pang F, et al. Pooling of chlamydial laboratory tests to determine prevalence of trachoma. Ophthalmic Epidemiol. 2001;8:109–117.